A detailed history of Tower Research Capital LLC (Trc) transactions in Opti Nose, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,274 shares of OPTN stock, worth $3,475. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,274
Previous 23,574 64.9%
Holding current value
$3,475
Previous $24,000 79.17%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.67 - $1.27 $10,251 - $19,431
-15,300 Reduced 64.9%
8,274 $5,000
Q2 2024

Aug 13, 2024

BUY
$0.82 - $1.44 $14,849 - $26,076
18,109 Added 331.36%
23,574 $24,000
Q1 2024

May 15, 2024

SELL
$1.17 - $1.94 $3,956 - $6,561
-3,382 Reduced 38.23%
5,465 $7,000
Q4 2023

Feb 13, 2024

SELL
$1.02 - $1.47 $575 - $829
-564 Reduced 5.99%
8,847 $11,000
Q3 2023

Nov 14, 2023

BUY
$0.93 - $1.38 $3,671 - $5,448
3,948 Added 72.27%
9,411 $11,000
Q2 2023

Aug 14, 2023

SELL
$1.11 - $2.05 $1,197 - $2,211
-1,079 Reduced 16.49%
5,463 $6,000
Q1 2023

May 09, 2023

BUY
$1.63 - $2.02 $5,783 - $7,166
3,548 Added 118.5%
6,542 $13,000
Q4 2022

Feb 10, 2023

SELL
$1.68 - $3.7 $7,596 - $16,731
-4,522 Reduced 60.16%
2,994 $6,000
Q3 2022

Nov 10, 2022

BUY
$3.43 - $4.01 $16,645 - $19,460
4,853 Added 182.24%
7,516 $28,000
Q2 2022

Aug 15, 2022

SELL
$1.76 - $3.82 $35,506 - $77,064
-20,174 Reduced 88.34%
2,663 $10,000
Q1 2022

May 12, 2022

BUY
$1.77 - $2.93 $34,665 - $57,384
19,585 Added 602.24%
22,837 $57,000
Q4 2021

Feb 14, 2022

BUY
$1.55 - $3.1 $2,205 - $4,411
1,423 Added 77.8%
3,252 $5,000
Q3 2021

Nov 15, 2021

SELL
$2.35 - $3.16 $9,670 - $13,003
-4,115 Reduced 69.23%
1,829 $5,000
Q2 2021

Aug 16, 2021

BUY
$2.91 - $3.83 $4,431 - $5,833
1,523 Added 34.45%
5,944 $18,000
Q1 2021

May 17, 2021

BUY
$3.47 - $4.75 $857 - $1,173
247 Added 5.92%
4,421 $16,000
Q4 2020

Feb 16, 2021

SELL
$3.2 - $4.98 $70,428 - $109,604
-22,009 Reduced 84.06%
4,174 $17,000
Q3 2020

Nov 16, 2020

BUY
$3.69 - $7.09 $75,811 - $145,664
20,545 Added 364.4%
26,183 $102,000
Q2 2020

Aug 13, 2020

BUY
$3.58 - $7.44 $19,811 - $41,172
5,534 Added 5321.15%
5,638 $42,000
Q1 2020

May 15, 2020

SELL
$3.49 - $9.2 $2,125 - $5,602
-609 Reduced 85.41%
104 $0
Q4 2019

Feb 07, 2020

SELL
$6.27 - $11.41 $100,307 - $182,537
-15,998 Reduced 95.73%
713 $7,000
Q3 2019

Nov 05, 2019

BUY
$4.75 - $8.38 $79,377 - $140,038
16,711 New
16,711 $117,000
Q2 2019

Aug 13, 2019

SELL
$6.4 - $10.94 $185 - $317
-29 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$6.1 - $10.3 $13,828 - $23,350
-2,267 Reduced 98.74%
29 $0
Q4 2018

Feb 14, 2019

BUY
$5.84 - $11.92 $9,320 - $19,024
1,596 Added 228.0%
2,296 $14,000
Q3 2018

Nov 13, 2018

BUY
$12.43 - $29.76 $6,103 - $14,612
491 Added 234.93%
700 $9,000
Q2 2018

Aug 15, 2018

SELL
$18.75 - $28.46 $15,543 - $23,593
-829 Reduced 79.87%
209 $6,000
Q1 2018

May 15, 2018

BUY
$15.91 - $20.82 $15,194 - $19,883
955 Added 1150.6%
1,038 $21,000
Q4 2017

Feb 09, 2018

BUY
$15.2 - $20.76 $1,261 - $1,723
83
83 $2,000

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $35M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.